News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|April 1, 2001

Is multichannel urodynamic testing essential before SUI surgery? No.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

5 women's health FDA headlines you missed in Q2 2026| Image credit: Contemporary OB/GYN

5 women's health FDA headlines you missed in Q2 2026

ByJoshua Fitch, Senior Editor

June 29th 2026

FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections | Image credit: Contemporary OB/GYN

FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections

ByJoshua Fitch, Senior Editor ,Benjamin P. Saylor

June 17th 2026

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

ByJoshua Fitch, Senior Editor

June 1st 2026

Nitrofurantoin outperformed fosfomycin for uncomplicated UTIs in randomized trial

Nitrofurantoin outperformed fosfomycin for uncomplicated UTIs in randomized trial

ByJoshua Fitch, Senior Editor

May 29th 2026

Aleece Fosnight, MSPAS, PA-C, on why new-onset incontinence in women warrants thyroid evaluation

ByAleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

March 25th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

Natural Cycles receives FDA clearance for AI-powered fertility algorithm

Late preterm hypoglycemia not tied to neurodevelopment at age 6

HIV screening, PrEP counseling get stronger ACOG recommendation